EUVIMEDAtrasti EUVIMED
Open access · CC BY-NC 4.0

AMIGO2 characterizes cancer‐associated fibroblasts in metastatic colon cancer and induces the release of paracrine active tumorigenic secretomes

Yongsong Yong iD, Richard Demmler iD, Bisan Abdalfatah Zohud, Qi Fang, Tong Zhang, Yonghua Zhou, Katja Petter, Christian Flierl, Tobias Gass, Carol I Geppert, Susanne Merkel, Vera S Schellerer and 2 more

The Journal of Pathology · 2025

DOI: 10.1002/path.6363 ↗

At a glance

Journal article in The Journal of Pathology, 2025. Written by Yongsong Yong and 13 co-authors. Institution: Division of Molecular and Experimental Surgery, Department of Surgery, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-…. Major MEDLINE topics: Cancer-Associated Fibroblasts, Paracrine Communication, Cell Proliferation, Cell Movement. Cited 1 times so far (Crossref); 51 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Forschungsstiftung Medizin am Universitätsklinikum Erlangen, Lutz Stiftung, Deutsche Forschungsgemeinschaft.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Secretomes of cancer‐associated fibroblasts (CAFs) in colorectal cancer (CRC) contribute to malignancy. Detailed knowledge is available on the components and functions of CAF secretomes. Little is known about the regulation of CAF secretomes. Here, we searched for receptor‐like membrane‐bound molecules in CAFs, which may regulate the production and release of tumor‐activating secretomes. The adhesion molecule with Ig‐like domain 2 (AMIGO2) was significantly upregulated in cultivated CAFs compared to normal tissue‐associated fibroblasts (NAFs), and this was confirmed in patient‐derived tissues. AMIGO2 expression was low or absent in healthy colon, significantly increased in fibroblasts of primary CRC, and highest in the stromal tissues of CRC‐derived liver metastases. AMIGO2 expression in CAFs correlated with a higher T‐category, increased lymph node metastasis, progressed tumor stages and was associated with reduced survival in different cohorts of CRC patients. Interestingly, AMIGO2 expression was induced by transforming growth factor‐β and higher in female patients, who exhibit a more aggressive disease course. In functional studies, conditioned media of NAFs with experimentally induced AMIGO2 overexpression enhanced proliferation and migration of different CRC tumor cells, while siRNA‐mediated inhibition of AMIGO2 in CAFs attenuated these effects. Accordingly, therapeutic inhibition of the receptor‐like AMIGO2 protein in CRC CAFs could prevent tumorigenic secretomes in CRC. © 2024 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Subjects

MeSH terms (MEDLINE)

Cancer-Associated FibroblastsParacrine CommunicationCell ProliferationCell MovementColonic NeoplasmsHumansFemaleMaleLiver NeoplasmsTumor MicroenvironmentGene Expression Regulation, NeoplasticCell Adhesion MoleculesMiddle AgedCell Line, TumorTransforming Growth Factor beta

Author keywords

cancer‐associated fibroblastscolorectal cancersecretionsecretomestumor microenvironment

Substances

Cell Adhesion MoleculesTransforming Growth Factor beta

Authors and institutions

  • Division of Molecular and Experimental Surgery, Department of Surgery, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany.
  • Xinghua People's Hospital Affiliated to Yangzhou University, Taizhou, PR China.
  • Institute of Pathology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany.
  • Department of Surgery, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany.
  • Department of Pediatric Surgery, University Medicine Greifswald, Greifswald, Germany.
  • CCC Erlangen-EMN: Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Universitätsklinikum Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany.

ORCID profiles: Yongsong Yong, Richard Demmler, Elisabeth Naschberger, Michael Stürzl

Funding

  • Forschungsstiftung Medizin am Universitätsklinikum Erlangen
  • Lutz Stiftung
  • Deutsche Forschungsgemeinschaft

Cite

APA

Yong, Y., Demmler, R., Zohud, B. A., Fang, Q., Zhang, T., Zhou, Y., Petter, K., Flierl, C., Gass, T., Geppert, C. I., Merkel, S., Schellerer, V. S., Naschberger, E., & Stürzl, M. (2025). AMIGO2 characterizes cancer‐associated fibroblasts in metastatic colon cancer and induces the release of paracrine active tumorigenic secretomes. The Journal of Pathology. https://doi.org/10.1002/path.6363

Vancouver

Yong Y, Demmler R, Zohud BA, Fang Q, Zhang T, Zhou Y, et al. AMIGO2 characterizes cancer‐associated fibroblasts in metastatic colon cancer and induces the release of paracrine active tumorigenic secretomes. The Journal of Pathology. 2025. doi:10.1002/path.6363

BibTeX
@article{Yong2025,
  author = {Yong, Yongsong and Demmler, Richard and Zohud, Bisan Abdalfatah and Fang, Qi and Zhang, Tong and Zhou, Yonghua and Petter, Katja and Flierl, Christian and Gass, Tobias and Geppert, Carol I and Merkel, Susanne and Schellerer, Vera S and Naschberger, Elisabeth and Stürzl, Michael},
  title = {AMIGO2 characterizes cancer‐associated fibroblasts in metastatic colon cancer and induces the release of paracrine active tumorigenic secretomes},
  journal = {The Journal of Pathology},
  year = {2025},
  doi = {10.1002/path.6363}
}
Start for free →